Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


03.07.2017

2 AJNR Am J Neuroradiol
1 Br J Neurosurg
1 Childs Nerv Syst
1 Clin Cancer Res
1 Eur J Cancer
2 J Neurooncol
1 J Neurosurg
4 Neuro Oncol
1 Neurosurgery
1 Oncogene
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. MARAVILLA KR, San-Juan D, Kim SJ, Elizondo-Riojas G, et al
    Comparison of Gadoterate Meglumine and Gadobutrol in the MRI Diagnosis of Primary Brain Tumors: A Double-Blind Randomized Controlled Intraindividual Crossover Study (the REMIND Study).
    AJNR Am J Neuroradiol. 2017 Jun 29. doi: 10.3174/ajnr.A5316.
    PubMed     Text format     Abstract available

  2. LIU Y, Xu X, Yin L, Zhang X, et al
    Relationship between Glioblastoma Heterogeneity and Survival Time: An MR Imaging Texture Analysis.
    AJNR Am J Neuroradiol. 2017 Jun 29. doi: 10.3174/ajnr.A5279.
    PubMed     Text format     Abstract available


    Br J Neurosurg

  3. NERY B, Costa RAF, Pereira LCT, Quaggio E, et al
    Spontaneous subdural hematoma associated with microcystic meningioma: first case report in the literature.
    Br J Neurosurg. 2017 Jun 29:1-4. doi: 10.1080/02688697.2017.1346172.
    PubMed     Text format     Abstract available


    Childs Nerv Syst

  4. RAGHU ALB, Kandasamy J, Brougham M, Gallo P, et al
    Delayed diffuse cerebellar swelling after resection of medulloblastoma: case report and review of literature.
    Childs Nerv Syst. 2017 Jun 29. doi: 10.1007/s00381-017-3496.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. ELLINGSON BM, Gerstner E, Smits M, Huang RY, et al
    Diffusion MRI phenotypes predict overall survival benefitfrom anti-VEGF monotherapy in recurrent glioblastoma:Converging evidence from phase II trials.
    Clin Cancer Res. 2017 Jun 27. pii: clincanres.2844.2016.
    PubMed     Text format     Abstract available


    Eur J Cancer

  6. GNEKOW AK, Walker DA, Kandels D, Picton S, et al
    A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (</=16 years) low grade glioma - A final report.
    Eur J Cancer. 2017;81:206-225.
    PubMed     Text format     Abstract available


    J Neurooncol

  7. AJLAN A, Thomas P, Albakr A, Nagpal S, et al
    Optimizing bevacizumab dosing in glioblastoma: less is more.
    J Neurooncol. 2017 Jun 30. doi: 10.1007/s11060-017-2553.
    PubMed     Text format     Abstract available

  8. LUBGAN D, Rutzner S, Lambrecht U, Rossler K, et al
    Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
    J Neurooncol. 2017 Jun 30. doi: 10.1007/s11060-017-2540.
    PubMed     Text format     Abstract available


    J Neurosurg

  9. MORSHED RA, Han SJ, Lau D, Berger MS, et al
    Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note.
    J Neurosurg. 2017 Jun 30:1-6. doi: 10.3171/2017.1.JNS161949.
    PubMed     Text format     Abstract available


    Neuro Oncol

  10. KIRKPATRICK JP, Soltys SG, Lo SS, Beal K, et al
    The radiosurgery fractionation quandary: single fraction or hypofractionation?
    Neuro Oncol. 2017;19.
    PubMed     Text format     Abstract available

  11. CAO Y, Tseng CL, Balter JM, Teng F, et al
    MR-guided radiation therapy: transformative technology and its role in the central nervous system.
    Neuro Oncol. 2017;19.
    PubMed     Text format     Abstract available

  12. QIAN Y, Maruyama S, Kim H, Pollom EL, et al
    Cost-Effectiveness of Radiation and Chemotherapy for High-Risk Low-Grade Glioma.
    Neuro Oncol. 2017 Jun 28. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. JIN L, Ge H, Long Y, Yang C, et al
    CD70, a novel target of CAR-T-cell therapy for gliomas.
    Neuro Oncol. 2017 Jun 23. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neurosurgery

  14. HIRSHMAN BR, Wilson B, Ali MA, Proudfoot JA, et al
    Superior Prognostic Value of Cumulative Intracranial Tumor Volume Relative to Largest Intracranial Tumor Volume Stereotactic Radiosurgery-Treated Brain Metastasis Patients.
    Neurosurgery. 2017 Jun 27. doi: 10.1093.
    PubMed     Text format     Abstract available


    Oncogene

  15. CONDUIT SE, Ramaswamy V, Remke M, Watkins DN, et al
    A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS One

  16. KUMAR R, de Mooij T, Peterson TE, Kaptzan T, et al
    Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane.
    PLoS One. 2017;12:e0179012.
    PubMed     Text format     Abstract available

  17. ZHAO P, Hall J, Durston M, Voydanoff A, et al
    BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma.
    PLoS One. 2017;12:e0179948.
    PubMed     Text format     Abstract available

  18. LEE JC, Chuang KS, Chen YW, Hsu FY, et al
    Preliminary dosimetric study on feasibility of multi-beam boron neutron capture therapy in patients with diffuse intrinsic pontine glioma without craniotomy.
    PLoS One. 2017;12:e0180461.
    PubMed     Text format     Abstract available

  19. FOSMARK S, Hellwege S, Dahlrot RH, Jensen KL, et al
    APNG as a prognostic marker in patients with glioblastoma.
    PLoS One. 2017;12:e0178693.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: